Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

Because of the biology of the brain, finding new treatments for glioblastoma has been difficult ... to fund the ...

The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.

While gliomas usually grow in the brain they can also form in the spinal cord. They are also difficult to reach and treat ...

A pioneering research study announced today (October 23) will trial multiple new treatments for people in the UK living with ...

Metrus, MDFact checked by Nick BlackmerA brain tumor can be diagnosed using imaging tests that view the structure of the brain, along with a biopsy, which can carefully assess a sample of a suspected ...

The initial trio of patients with glioblastoma have begun treatment with ropidoxuridine in a phase 2 clinical trial, ...

The FDA accepted the new drug application for TLX101-CDx and granted priority review to the agent in glioma. The FDA has ...

The FDA has approved the Ion Torrent Oncomine Dx Target Test as a companion diagnostic to identify patients eligible for ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea ...

October 4, 2024 Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent ...